Market Newsdesk

ANDOVER, Mass., Dec. 07, 2020 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) won the 2020 Global Semiconductor Alliance (GSA) Award for Analyst Favorite Semiconductor Company. Vicor high-efficiency, high-density power system solutions enable advances in artificial intelligence and other demanding applications. Vicor was among five companies nominated in this category including AMD, NVIDIA, Inphi Corporation and SiTime Corporation.

Semiconductor financial analysts from two top-tier firms selected their favorite semiconductor company for this award. The analysts based their decision on historical as well as projected data such as stock price, earnings per share, revenue forecasts and product performance.

The 2020 GSA Awards recognize leading semiconductor companies that have exhibited market growth through technological innovation and exceptional business management strategies.

Learn more about the award and watch the virtual presentation.

About Vicor

Vicor Corporation designs, develops, manufactures and markets modular power components and complete power systems based upon a portfolio of patented technologies. Headquartered in Andover, Massachusetts, Vicor sells its products to the power systems market, including enterprise and high-performance computing, industrial equipment and automation, telecommunications and network infrastructure, vehicles and transportation, and aerospace and defense.
www.vicorpower.com

About GSA

GSA is Where Leaders Meet to establish an efficient, profitable and sustainable semiconductor and high technology global ecosystem encompassing semiconductors, software, solutions, systems and services. It is a leading industry organization that provides a unique neutral platform for collaboration, where global executives interface and innovate with peers, partners and customers to accelerate industry growth and maximize return on invested and intellectual capital. GSA has an impressive global footprint representing over 25 countries and 250+ corporate members, including 100 public companies. As a result of its unique, neutral platform, GSA membership ranges from the most exciting, emerging companies to semiconductor industry stalwarts and technology leaders, together representing 70% of the $450B-plus semiconductor industry.
www.gsaglobal.org

Media contacts:

Vicor

Colin Boroski
Rainier Communications
[email protected]

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/3603020c-f595-47e8-ab70-a5c898f73092

CERRITOS, CALIFORNIA, Dec. 07, 2020 (GLOBE NEWSWIRE) — (Nasdaq Capital Markets: FCBP) – First Choice Bancorp, the holding company for First Choice Bank (the “Bank” or “First Choice”), today announced that the Bank’s fundraising efforts for 2020 will be directed to 18 local charities in the Los Angeles, Orange and San Diego County areas. These organizations, helping those most in need in our communities, are facing even higher demand for services during these unprecedented times. Thanks to the tremendous generosity of First Choice clients, employees, directors and friends, along with dollar-for-dollar matches by the Bank and the Much is Given Foundation, this year’s contribution to the selected nonprofit organizations totals $60,000.

In light of the COVID-19 pandemic, First Choice made the difficult decision to cancel its Annual Charity Golf Tournament, which began back in 2010. For the last decade, the yearly tournament has supported various charitable organizations in local neighborhoods as they provide assistance to families and individuals in need of help. “One of the Bank’s core beliefs is to always look for opportunities to make a positive impact on the communities where we live and work, not because it is required, but because it is the right thing to do,” said Chairman Peter Hui. Despite the obstacles for an in-person event this year, there was still a critical need to raise money to support these charities, so an online fundraising effort was put into place. First Choice President & CEO Robert Franko commented, “We missed seeing all of our friends at the tournament this year, but we are proud of the fundraising response we received, especially given the impact the pandemic has had on our donors. We are grateful for so many supporting this year’s charities and look forward to getting together again at FCB’s 2021 tournament to raise even more money for those in need.”

The 18 non-profit organizations this year were: Asian Pacific Community Fund, Blind Children’s Learning Center, C5 Los Angeles, Caterina’s Club, Central City Neighborhood Partners, East West Players, The Entrepreneur Educational Center Inc., Food Finders, Haven Neighborhood Services, Joy Youth Services, Kitchens For Good, Milal- The American Wheat Mission, National Asian American Coalition, Orange County Community Housing Corporation, Pomona Valley Habitat for Humanity, Saddleback Church Anaheim Food Pantry, The Jacobs & Cushman San Diego Food Bank, and Weingart East Los Angeles YMCA. More information on each organization can be found on the Bank’s website: https://www.firstchoicebankca.com/annual-charity-golf-tournament.

About First Choice Bancorp

First Choice Bancorp, headquartered in Cerritos, California, is the sole shareholder of and the registered bank holding company for, First Choice Bank. As of September 30, 2020, First Choice Bancorp had total consolidated assets of $2.26 billion. First Choice Bank, also headquartered in Cerritos, California, is a community-based financial institution that serves primarily commercial and consumer clients in diverse communities and specializes in loans to small- to medium-sized businesses and private banking clients, commercial and industrial loans, and commercial real estate loans. First Choice Bank is a Preferred Small Business Administration (SBA) Lender. First Choice Bank conducts business through nine full-service branches and two loan production offices located in Los Angeles, Orange and San Diego Counties. Founded in 2005, First Choice Bank has quickly become a leading provider of financial services that enable our customers to grow, maintain strength, and achieve their business objectives. We strive to surpass our clients’ expectations through our efficiency, personalized services and financial solutions and professionalism and are committed to being “First in Speed, Service, and Solutions.” First Choice Bank is proud to be designated by the FDIC as a Minority Depository Institution (MDI) and to be certified through the U.S. Department of Treasury as a Community Development Financial Institution (CDFI). First Choice Bank is a strong believer in social justice and equality and is proud of its cultural- and gender-diverse workforce. As of September 30, 2020, more than 71% of the Company’s total workforce identified as ethnic minorities and more than 66% of its workforce and more than 50% of its senior management identified as female. First Choice Bancorp stock is traded on the Nasdaq Capital Market under the ticker symbol “FCBP.”

First Choice Bank’s website is www.FirstChoiceBankCA.com.

FORWARD-LOOKING STATEMENTS

The statements contained herein that are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and are based on management’s current expectations and beliefs concerning future developments and their potential effects on the Company including, without limitation, plans, strategies and goals, and statements about the Company’s expectations regarding revenue and asset growth, financial performance and profitability, loan and deposit growth, yields and returns, loan diversification and credit management, shareholder value creation and tax rates. There can be no assurance that future developments affecting the Company will be the same as those anticipated by management. Actual results may differ materially from those set forth in the forward-looking statements due to a variety of factors, including the risk factors described in documents filed by the Company with the Securities and Exchange Commission.

The Company does not undertake, and specifically disclaims any obligation, to update any forward-looking statements to reflect occurrences or unanticipated events or circumstances after the date of such statements except as required by law. Any statements about future operating results, such as those concerning accretion and dilution to the Company’s earnings or shareholders, are for illustrative purposes only, are not forecasts, and actual results may differ.

CONTACT

First Choice Bank
Robert M. Franko, 562.345.9241
President & Chief Executive Officer
or
Khoi D. Dang, 562.263.8336
Executive Vice President & General Counsel

ENGLEWOOD, Colo., Dec. 07, 2020 (GLOBE NEWSWIRE) — Evolving Systems, Inc. (Nasdaq: EVOL), a leader in real-time digital engagement solutions and services, anticipates a challenging but potentially rewarding year ahead for Communications Service Providers (CSPs) in 2021. Evolving Systems’ leaders expect a number of pressing issues to come to the fore and dominate strategic decision-making in the industry over the next twelve months. These include the following.

The telecoms industry will continue to evolve rapidly both in spite of and as a result of the pandemic:

• 5G will continue to roll out with end-users potentially benefitting from more reliable high speed Internet access, while the operators increase their bandwidth capacity allowing them to target new subscriber growth via new services or by taking a bigger share of the marketplace.
• There will be an increasing focus and determination to capitalize on customers’ trust. Data intimacy, which is yet to be won, can untap many different plays; from digital ID to optimized operations.
• Expect a further effort to capitalize on the customer data AI offers the opportunity for, a quantum leap in customer experience enhancement by utilizing the data to improve targeting and personalization; getting the right offer, right moment, right customer and right channel thanks to an integrated customer view.
• Content monetization will continue to drive alternative revenue streams. The trends towards commoditization of connectivity leaves video as the main element of differentiation, fueled by AI-driven customization. Growth of video streaming will continue to explode with the ‘reaggregation’ (or rebundling) of streaming offerings, an approach pioneered by players like Amazon and Roku.
• The development of the next generation of use cases based on 5G will continue. These include:
  °  Video surveillance and analytics
  °  Fixed Wireless Access
  °  Immersive experiences
  °  Smart stadiums
  °  eHealth services
  °  Machine remote control
  °  Cloud robotics and process automation Connected Vehicles
• We expect there will be greater investment by telcos in networks and platforms next year rather than less. Social lifestyle will continue to evolve from no lifestyle restriction to semi-lifestyle restriction for the better part of 2021. Some business will cease, some business will flourish. New and innovative digital enterprises will emerge. For CSPs, this means either investing in new enterprise applications or acquisition or partnerships from e-Wallets to Virtual malls, OTT services, etc.
• Impacts on revenues from the pandemic will mean costs will not only continue to be a focus for telephony services but will be thrust to the top of the agenda. While consumers will struggle with bills and cashflow may be affected, use of mobile will continue to grow, especially data. Services such as Zoom have seen significant growth, as has online shopping and mobile data will continue to enable that. Operators have a unique opportunity to encourage merchants to provide mobile-based services to encourage online shopping. While classic broadband is available in more developed economies, developed economy infrastructure means mobile is crucial for online access. Operators will continue to build their presence in the SME space, providing services to enable retailers to sell online.

Network and Activation teams face new challenges

• eSIM will continue to be implemented but will not hit massive numbers as devices with eSIM capability will remain out of reach for the average person. Nevertheless, meeting eSIM infrastructure requirements comes into play now so that, as use of the technology expands, CSPs are ready.
• IoT will develop in logistics and delivery, with online sales (due to the pandemic) driving a need for more efficiency to cope with the increased load.
• KYC regulation will adjust as the practicalities of an in-person check limits sales and competition among operators.

2021 will see Customer Value and Loyalty programs being reinvented; at least the most successful ones

• Operators will continue the search for complimentary offers for consumer and SMEs as their service bundles still tend towards ‘all-you-can-eat’.
• Winning the hearts and minds of our customers will become a core goal. Great customer experience is powerful. It can provide the important emotional connection that is the ‘missing multiplier’ between operations and what the customer feels. As a result, there will be a focus on building real and meaningful relationships, constantly listening and analyzing customer needs and then adapting quickly to stay relevant and add value ‘in the moment’.
• There will be a new approach to marketing where success is defined from solving customer problems, not pushing products. The CSP will transform activities from traditional, product-push marketing to engaging customers one-to-one.
• Conversational marketing will move beyond the simple chatbot, and simple inbound and outbound communication will be replaced by a new approach – interactive, conversational marketing.
• The pandemic has changed consumer sentiment with the result that people are adopting digital habits more rapidly than before and also trying new products and services as a result. Necessity (and lockdown) have been the mothers of invention which translates to new opportunities for connecting with segments that brands previously couldn’t reach. With that said, other players are going to reach your consumers too so CSPs will need to work harder on their loyalty progams than ever before.

Matthew Stecker, CEO, Evolving Systems, noted: “2021 will again be challenging for CSPs as traditional end-user expectations have been and continue to be reset in light of the pandemic. But it will also be a year of great opportunity, with internal support infrastructures being redrawn. Those who move quickly to address the challenges will reap substantial rewards in the medium- and long-terms as they emerge from a difficult period well positioned to succeed in a new world. At Evolving Systems, we know better than anyone how state-of-the-art customer communications programs work and the benefits they can deliver in the telecoms industry. Those carriers who are driving innovation in their relationships with customers in this highly competitive market will be the industry leaders for years ahead.”

About Evolving Systems^®

Evolving Systems, Inc. (NASDAQ: EVOL) is a provider of real-time digital engagement solutions and services to more than 100 customers in over 60 countries worldwide. The Company’s portfolio includes market-leading solutions and services for real-time analytics, customer acquisition, customer value management and loyalty for telecom, retail and financial services companies. Founded in 1985, the Company has its headquarters in Englewood, Colorado, with offices in Asia, Europe, Africa, South America and North America. For more information, please visit www.evolving.com

F
ollow us on:


LinkedIn



Twitter

Media &
Analyst
Relations:
Sancha
Brody


[email protected]

/
+44 (0) 7376 366855

AUSTIN, Texas, Dec. 07, 2020 (GLOBE NEWSWIRE) — A Cloud Guru (ACG), a leader in modern tech skills development, today announced that it’s been selected as a Microsoft Training Partner. Additionally, ACG will join the Partner Steering Committee to assist in advancing technical skilling strategies across Microsoft’s entire portfolio.

A Cloud Guru and Microsoft will specifically collaborate to enhance the resources available for users looking to become Microsoft Azure Fundamentals certified. By integrating A Cloud Guru’s hands-on AZ-900 course and labs with Microsoft Learn’s content, users will experience an enhanced learning journey where they can develop practical Azure skills in a risk-free environment.

“Microsoft Azure content on A Cloud Guru has seen record-breaking traction this year,” said Sam Kroonenburg, CEO of A Cloud Guru. “Azure minutes watched on A Cloud Guru were up over 10x in September compared to last year. As the Azure portfolio continues to grow, our hands-on courses and labs have helped hundreds of thousands of people gain in-demand Azure skills and accelerate their careers in the cloud. As an official Microsoft Training Partner, we’re eager to see our impact on the Azure community grow even stronger.”

“The AZ-900 certification is the foundational course for establishing cloud fluency in Microsoft Azure, and we want our users to have access to a range of resources that will help them succeed,” said Alex Payne, Microsoft General Manager of Global Technical Learning. “With course content designed and curated by ACG architects, A Cloud Guru creates course material that’s fun, digestible and hands-on for people at all skill levels. Their approach is aligned with Microsoft Learn, making it a natural addition to our partner network and steering committee.”

A Cloud Guru has a broad, constantly updated library of Azure courses and labs. Additionally, its Cloud Playground helps learners get practical experience with Azure technologies and servers and offers a safe practice environment for people to learn by doing. To check out A Cloud Guru’s full Azure course library, see here. To access A Cloud Guru’s AZ-900 Microsoft Azure Fundamentals 2020 course, see here.

About A Cloud Guru

A Cloud Guru is driven by a simple mission — to teach the world to cloud. We believe people learn best by doing. That’s why our in-house cloud experts go to ridiculous lengths to design fresh, engaging, and hands-on learning tools that empower both individuals and organizations to stay ahead of the technology curve. As the world’s most comprehensive, hands-on, and effective platform for cloud learning, ACG has enabled more than 2 million learners and 4,000 organizations to achieve a brighter future.

Contact

[email protected]

REDWOOD CITY, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Sumo Logic (Nasdaq: SUMO), the pioneer in continuous intelligence, today announced the appointment of Tracey Newell to its board of directors as an independent board member to help guide Sumo Logic’s growth and market leadership.

“We continue to see new opportunities and use cases across operational, security and business intelligence, which is helping to fuel our continued growth, expansion and success in the market as the pioneer of continuous intelligence,” said Ramin Sayar, president and CEO, Sumo Logic. “Tracey’s impressive go-to-market expertise across sales, customer success and marketing will make for a strong addition to the experienced board and help Sumo Logic as we move into the next phase of our journey as a public company.”

Newell brings deep go-to-market experience in high-growth software companies. As President of Informatica’s global sales, marketing and customer success teams, she is instrumental in driving Informatica’s growth engine. Prior to joining Informatica, Newell was executive vice president of global field operations at Proofpoint. Under her leadership, Proofpoint saw rapid growth, becoming a top five leader in the cybersecurity market. She has also led high-growth sales leadership teams at Polycom, Juniper Networks and at Cisco WebEx. Recognized as a Top 100 Sales Leader by The Modern Sale, Newell currently serves on the board of directors of SailPoint.

“As a cloud-native company, Sumo Logic is already well positioned to help enterprises scale to meet the demand of digital business, and derive actionable insights more effectively in order to build, manage and secure modern digital services,” said Tracey Newell, president at Informatica. “I have been following Sumo Logic’s continued growth and success for years, and I am thrilled to join such an experienced and distinguished board and management team as the company scales to the next level.”

Additional Resources

• 
  Learn more
  about Sumo Logic’s Continuous Intelligence Platform™
• 
  Sign up
  for a free trial of Sumo Logic

About Sumo Logic

Sumo Logic Inc. (Nasdaq: SUMO) is the pioneer in continuous intelligence, a new category of software, which enables organizations of all sizes to address the data challenges and opportunities presented by digital transformation, modern applications, and cloud computing. The Sumo Logic Continuous Intelligence Platform™ automates the collection, ingestion, and analysis of application, infrastructure, security, and IoT data to derive actionable insights within seconds. More than 2,100 customers around the world rely on Sumo Logic to build, run, and secure their modern applications and cloud infrastructures. Only Sumo Logic delivers its platform as a true, multi-tenant SaaS architecture, across multiple use-cases, enabling businesses to thrive in the Intelligence Economy. For more information, visit www.sumologic.com.

Sumo Logic is a trademark or registered trademark of Sumo Logic in the United States and in foreign countries. All other company and product names may be trademarks or registered trademarks of their respective owners.

Any information regarding offerings, updates, functionality, or other modifications, including release dates, is subject to change without notice. The development, release, and timing of any offering, update, functionality, or modification described herein remains at the sole discretion of Sumo Logic, and should not be relied upon in making a purchase decision, nor as a representation, warranty, or commitment to deliver specific offerings, updates, functionalities, or modifications in the future.

Media Con
tact

Melissa Liton
Sumo Logic
[email protected]
(650) 814-3882

Company Installing Coronavirus Neutralizing Air Purification System Across its 28 Ship Fleet

New Green Air Technology to Feature Continuous Active COVID Disinfection through Bi-polar Ionization in the Air and on Surfaces

MIAMI, Dec. 07, 2020 (GLOBE NEWSWIRE) — Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (“Norwegian” or the “Company”) today announces a partnership with AtmosAir Solutions to install continuous disinfection air purification systems across its 28 ship fleet for its three brands, Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises. The new air filtration system technology will feature continuous active COVID disinfection through bi-polar ionization in the air and on surfaces, an all-natural solution with no harmful chemicals, radiations or by-products. One of the advantages of the bi-polar ionization process is that it allows air purification to occur within the desired space, treating a larger volume of air, instead of relying on contaminants passing through the air handler unit to be cleaned.

Tests performed by Microchem Laboratory, one of the world’s preeminent laboratories for testing EPA- and FDA-registered sanitizing products, confirmed that the presence of coronavirus was reduced by 99.92% within 30 minutes of exposure to AtmosAir.

“While it is impossible to completely eliminate the risks associated with COVID-19, the AtmosAir technology is one of the many investments the Company is making to enhance its already rigorous health and safety standards,” said Robin Lindsay, executive vice president of Vessel Operations for Norwegian Cruise Line Holdings Ltd. “We are working diligently on our multi-layered strategy for health and safety and AtmosAir’s proven all-natural bi-polar ionization technology will add yet another layer of protection on board our ships.”

“We are proud to partner with Norwegian Cruise Line Holdings on making their fleet safer for their guests and crew members,” Steve Levine, President & CEO of AtmosAir Solutions. “In order to get everyone back to work and back to having fun, people need to know that the spaces they occupy are safe, and AtmosAir adds a significant layer of protection, giving people confidence in the air they breathe. We look forward to seeing their fleet back on the high seas.”

AtmosAir’s patented bi-polar ionization technology continually and proactively attacks coronavirus and other viruses, bacteria, spores and volatile organic compounds quickly and effectively in the air and on surfaces, rather than requiring the air to be filtered out first. The technology works by releasing ions through the HVAC system, and these ions bond with viruses, breaking down their cellular structure and rendering them harmless. AtmosAir is providing cleaner air using a safe, natural and environmentally friendly process and helping protect cruise ships, airports, casinos, sports facilities, educational institutions, commercial buildings and a host of other spaces where people live, work and enjoy themselves worldwide with more than 7,500 locations across the globe currently using this technology.

About Norwegian Cruise Line Holdings Ltd.

Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) is a leading global cruise company which operates the Norwegian Cruise Line, Oceania Cruises and Regent Seven Seas Cruises brands. With a combined fleet of 28 ships with approximately 59,150 berths, these brands offer itineraries to more than 490 destinations worldwide. The Company has nine additional ships scheduled for delivery through 2027.

About
AtmosAir
Solutions

AtmosAir Solutions of Fairfield, CT provides clean green indoor air technology for commercial buildings, health care, hospitals, assisted living, hotels, cruise lines, universities and sports facilities. The company’s patented bi-polar ionization technology is over 99% effective in neutralizing coronavirus. Tests performed by Microchem Laboratory, one of the world’s preeminent laboratories for testing sanitizing products registered by the EPA and FDA, confirmed that the presence of coronavirus was reduced by 99.92 percent within 30 minutes of exposure to the AtmosAir’s bi-polar ion technology. AtmosAir’s technology improves wellness, makes buildings more sustainable, reduces their operational costs and its proven air purification technology is a continuous disinfectant, removing airborne and surface contaminants from indoor spaces. With more than 7,500 installations worldwide, AtmosAir’s patented bi-polar ionization technology suppresses airborne and surface microbials and pathogens, including viruses, bacteria and mold, and reduces odors as well as unhealthy and irritating volatile organic compounds (VOCs). More information can be found at www.atmosair.com.

Cautionary Statement Concerning Forward-Looking Statements

Some of the statements, estimates or projections contained in this release are “forward-looking statements” within the meaning of the U.S. federal securities laws intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this release, including, without limitation, those regarding our business strategy, financial position, results of operations, plans, prospects, actions taken or strategies being considered with respect to our liquidity position, valuation and appraisals of our assets and objectives of management for future operations (including those regarding expected fleet additions, our voluntary suspension, our ability to weather the impacts of the COVID-19 pandemic and the length of time we can withstand a suspension of voyages, our expectations regarding the resumption of cruise voyages and the timing for such resumption of cruise voyages, the implementation of and effectiveness of our health and safety protocols, operational position, demand for voyages, financing opportunities and extensions, and future cost mitigation and cash conservation efforts and efforts to reduce operating expenses and capital expenditures) are forward-looking statements. Many, but not all, of these statements can be found by looking for words like “expect,” “anticipate,” “goal,” “project,” “plan,” “believe,” “seek,” “will,” “may,” “forecast,” “estimate,” “intend,” “future” and similar words. Forward- looking statements do not guarantee future performance and may involve risks, uncertainties and other factors which could cause our actual results, performance or achievements to differ materially from the future results, performance or achievements expressed or implied in those forward-looking statements. Examples of these risks, uncertainties and other factors include, but are not limited to the impact of: the spread of epidemics, pandemics and viral outbreaks and specifically, the COVID-19 pandemic, including its effect on the ability or desire of people to travel (including on cruises), which are expected to continue to adversely impact our results, operations, outlook, plans, goals, growth, reputation, cash flows, liquidity, demand for voyages and share price; our ability to comply with the CDC’s Framework for

Conditional Sailing Order and to otherwise develop enhanced health and safety protocols to adapt to the current pandemic environment’s unique challenges once operations resume and to otherwise safely resume our operations when conditions allow; coordination and cooperation with the CDC, the federal government and global public health authorities to take precautions to protect the health, safety and security of guests, crew and the communities visited and the implementation of any such precautions; our ability to work with lenders and others or otherwise pursue options to defer, renegotiate or refinance our existing debt profile, near-term debt amortization, newbuild related payments and other obligations and to work with credit card processors to satisfy current or potential future demands for collateral on cash advanced from customers relating to future cruises; our potential future need for additional financing, which may not be available on favorable terms, or at all, and may be dilutive to existing shareholders; our indebtedness and restrictions in the agreements governing our indebtedness that require us to maintain minimum levels of liquidity and otherwise limit our flexibility in operating our business, including the significant portion of assets that are collateral under these agreements; the accuracy of any appraisals of our assets as a result of the impact of COVID-19 or otherwise; our success in reducing operating expenses and capital expenditures and the impact of any such reductions; our guests’ election to take cash refunds in lieu of future cruise credits or the continuation of any trends relating to such election; trends in, or changes to, future bookings and our ability to take future reservations and receive deposits related thereto; the unavailability of ports of call; future increases in the price of, or major changes or reduction in, commercial airline services; adverse events impacting the security of travel, such as terrorist acts, armed conflict and threats thereof, acts of piracy, and other international events; adverse incidents involving cruise ships; adverse general economic and related factors, such as fluctuating or increasing levels of unemployment, underemployment and the volatility of fuel prices, declines in the securities and real estate markets, and perceptions of these conditions that decrease the level of disposable income of consumers or consumer confidence; any further impairment of our trademarks, trade names or goodwill; breaches in data security or other disturbances to our information technology and other networks or our actual or perceived failure to comply with requirements regarding data privacy and protection; changes in fuel prices and the type of fuel we are permitted to use and/or other cruise operating costs; mechanical malfunctions and repairs, delays in our shipbuilding program, maintenance and refurbishments and the consolidation of qualified shipyard facilities; the risks and increased costs associated with operating internationally; fluctuations in foreign currency exchange rates; overcapacity in key markets or globally; our expansion into and investments in new markets; our inability to obtain adequate insurance coverage; pending or threatened litigation, investigations and enforcement actions; volatility and disruptions in the global credit and financial markets, which may adversely affect our ability to borrow and could increase our counterparty credit risks, including those under our credit facilities, derivatives, contingent obligations, insurance contracts and new ship progress payment guarantees; our inability to recruit or retain qualified personnel or the loss of key personnel or employee relations issues; our reliance on third parties to provide hotel management services for certain ships and certain other services; our inability to keep pace with developments in technology; changes involving the tax and environmental regulatory regimes in which we operate; and other factors set forth under “Risk Factors” in our most recently filed Annual Report on Form 10-K, Quarterly Report on Form 10-Q and subsequent filings with the Securities and Exchange Commission. Additionally, many of these risks and uncertainties are currently amplified by and will continue to be amplified by, or in the future may be amplified by, the COVID-19 pandemic. It is not possible to predict or identify all such risks. There may be additional risks that we consider immaterial or which are unknown. The above examples are not exhaustive and new risks emerge from time to time. Such forward-looking statements are based on our current beliefs, assumptions, expectations, estimates and projections regarding our present and future business strategies and the environment in which we expect to operate in the future. These forward-looking statements speak only as of the date made. We expressly disclaim any obligation or undertaking to release publicly any updates or revisions to any forward-looking statement to reflect any change in our expectations with regard thereto or any change of events, conditions or circumstances on which any such statement was based, except as required by law.

Investor Relations & Media Contact

Andrea DeMarco

(305) 468-2339 [email protected] Jessica John (786) 913-2902

MIAMI, Dec. 07, 2020 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced today it has entered into a partnership (the “Agreement”) with Identity Key to provide blockchain based identity verification software for the medical industry. The Agreement calls for the Identity Based Plug-in to be integrated into Ehave’s Dashboard. Ehave will generate royalty revenue based on sales of identity verification software from Identity Key. Ehave currently has products in development that focus on telemedicine, providing medical data, and regulated substance research for mental health. Identity Key is a software company that focuses on creating verifiable credentials for users through the blockchain. Blockchain technology is creating huge opportunities for patients, doctors, and researchers to access data in new ways with audit trails and verifiable authentication.

“Online ID verification is seeing a spike in demand driven by the current pandemic. As many medical professionals send their staff to work remotely during the pandemic there has been a strong surge in demand for videoconferencing communication. Patient identification and verification is one of the most difficult issues the healthcare sector faces during these turbulent times, but it is critical in imparting fast and effective healthcare services to patients,” said Ben Kaplan, Chief Executive officer of Ehave. Mr. Kaplan continued, “Our research indicates digital identity verification systems can benefit healthcare providers by improving the quality of healthcare they provide. We see this opportunity to provide the blockchain based identity verification software from Identity Key to the medical industry as a means to enable them to improve organization and sharing of medical records, ensure insurance claims and reduce medical fraud by protecting patient data.”

According to MarketsandMarkets™ Research Private Ltd., “The post-COVID 19 global identity verification market size is expected to grow from USD 7.6 billion in 2020 to USD 15.8 billion by 2025, at a Compound Annual Growth Rate (CAGR) of 15.6% during the forecast period. The major factors fueling the identity verification market include increasing digitization initiatives, increase in fraudulent activities and identity theft during the last decade and increasing use cases of digital identities among verticals.”¹

“Making each person the center of their data has some exciting benefits,” said Adam Lambert founder of Identity Key. “Decentralized identity, puts patients in control of the entirety of their medical data, sharing only what is needed, when, and with whom.”

Identity Key technology provides a way to verify the source of information (Issuer) by establishing a unique, secure, direct line of communication between a data holder (Patient) and a data verifier (Recipient). This provides a layer of trust while preserving privacy and ensuring data protection.

Attestations about personally identifiable information are trusted, as they are digitally signed by a trusted issuer and can be verified cryptographically, without any data mediators.

Ehave plans to target patients, doctors, and researchers to help them quickly authenticate or release personal, verified data and give more control in situations where trust cannot be compromised. Utilizing the blockchain technology Ehave can offer its medical partners an opportunity to lower their administration costs by up to 90%. Ehave intends to offer its medical partners identity management solutions that include:

 – Verifying Patient Data prior to telemedicine.

 – Allowing the patient to control access to their medical files.

 – Allow partners to verify medical insurance faster.

 – Allow patients to share parts of their health information but maintain privacy.

By verifying patients, doctors, and medical partners faster and more securely, Ehave should be able to offer a significant savings on administration costs. This creates a very secure tool that ensures a more secure verification process and increase profits for medical professionals by lowering the cost of revenue.

Additional Ehave Inc. Statement

We are truly grateful for the patience and support of EHVVF shareholders! Please join the conversation on our Ehave supporter’s telegram group at https://t.me/EhaveInc.

The company diligently posts important information and updates through weekly videos from the official company YouTube channel https://www.youtube.com/channel/UCnyW1mgMd0qmYkEMq3O6FWA.

About Ehave, Inc.

Ehave, Inc. (EHVVF) is a leader of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes. Our main product is the Ehave Telemetry Portal, which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insights. The Ehave Infinity Portal offers a powerful machine learning and artificial intelligence platform with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools. For more information visit: www.ehave.com.

Forward-Looking Statement Disclaimer

This press release contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words “intends,” “may,” “will,” “plans,” “expects,” “anticipates,” “projects,” “predicts,” “estimates,” “aims,” “believes,” “hopes,” “potential” or similar words. Forward-looking statements are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the Company’s control, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements: (i) the initiation, timing, progress and results of the Company’s research, manufacturing and other development efforts; (ii) the Company’s ability to advance its products to successfully complete development and commercialization; (iii) the manufacturing, development, commercialization, and market acceptance of the Company’s products; (iv) the lack of sufficient funding to finance the product development and business operations; (v) competitive companies and technologies within the Company’s industry and introduction of competing products; (vi) the Company’s ability to establish and maintain corporate collaborations; (vii) loss of key management personnel; (viii) the scope of protection the Company is able to establish and maintain for intellectual property rights covering its products and its ability to operate its business without infringing the intellectual property rights of others; (ix) potential failure to comply with applicable health information privacy and security laws and other state and federal privacy and security laws; and (x) the difficulty of predicting actions of the USA FDA and its regulations. All forward-looking statements included in this press release are made only as of the date of this press release. The Company assumes no obligation to update any written or oral forward-looking statement unless required by law. More detailed information about the Company and the risk factors that may affect the realization of forward-looking statements is contained under the heading “Risk Factors” in Ehave, Inc.’s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, http://www.sec.gov.

For Investor Relations, please contact:

Gabe Rodriguez

Phone: (623) 261-9046

Email: [email protected]

<sup>____________________________

1</sup> https://www.marketsandmarkets.com/Market-Reports/identity-verification-market-178660742.html 

Founding Members Look to Provide Operators with Best Practices and Equipment in Raw Material Manufacturing

BUDAPEST, HUNGARY, Dec. 07, 2020 (GLOBE NEWSWIRE) — via NewMediaWire – Global Allied Processing Solutions (“G-APS” or “Organization”) today announced its strategic focus on the global organic material industry through its recent formation of an alliance representing companies on the forefront of technological advancements in processing equipment and practices. Founding members RotaChrom Technologies, the developer of the world’s first industrial-scale Centrifugal Partition Chromatography (CPC) technology platform, and Heidolph Instruments, the leader in the production of premium laboratory equipment, created G-APS to further establish best practices for the processing of raw materials through education and innovative equipment offerings.

RotaChrom and Heidolph formed G-APS through a shared vision and understanding of the global processing marketplace spanning several industries including pharmaceuticals, natural extracts, food and beverages, and cosmetics and fragrances. The Organization’s goal is to provide businesses with one-stop-shop access to multiple solutions for their processing and manufacturing infrastructure needs, with a specific focus on the extraction and purification of botanically-derived compounds and molecules. G-APS’ mission is to provide businesses with a vetted network of worldwide equipment suppliers that have proven results and work together seamlessly – avoiding potential overhead costs and risks when pairing machines that have not been previously tested in manufacturing settings.

“There are many nuances regarding equipment selection and production processes that must be taken into account when designing a fully functional processing facility,” said RotaChrom CEO László Madarász. “As operators in rapidly growing markets must navigate through an increasingly complex landscape to support their business’s success, we sought to build an alliance of vetted companies offering cutting-edge solutions to the processing segment of multiple industries’ supply chain.”

RotaChrom North America President Gyula Kangiszer stressed the importance of integrated solutions: “Customers face many challenges when trying to optimize ‘mix and match’ equipment. We are proud to provide a solution by combining our company’s technologies with other leading providers to create this much needed network.”

Founding companies RotaChrom and Heidolph are high-end equipment producers in the respective fields of purification and solvent recovery. The combination of the two founding members’ technologies resulted in a highly efficient system based on an optimized collaborative working principle that G-APS will expand upon with the addition of other member companies. To showcase the synergies between the companies’ equipment, the Organization in installing showrooms in multiple locations in Europe and North America. G-APS will announce more information when the installations are ready for public access.

“When we first paired our systems, we found that they were perfectly balanced and highly automated, allowing us to achieve increased throughput while providing unmatched quality results,” said Heidolph Instruments CEO Wolfgang Jaenicke. “We recognized that like-minded equipment companies should align to offer a full suite of resources to increase operational stability and find solutions in processing that allow greater capacity and automation, decrease costs, and increase output. Instead of operators being forced to piece together systems and test their efficiencies on a case-by-case basis, G-APS provides a coalition of equipment manufacturers whose technologies operate in tandem with one another. We hope to engage with other manufacturers who provide equipment for the processing phase of various supply chains, vet them on the basis of quality and safety, and build systems that are predetermined to give operators the ultimate result they are seeking.”

Heidolph North America President Jim Dawson added, “We are confident this value-add type of organization will not only be beneficial for our customers, but for the industry as a whole. Due to rising demand for more sophisticated solutions for separation, this partnership brings together two world class technologies resulting in an automated high precision separation for end users.”

G-APS aims to set standards for the processing industry as well as bring strategic cooperation, shared research and development, integrated project and sales activities, and value-add metrics needed for forward-thinking innovation. In addition to efficiency, the alliance is committed to bringing together systems that are flexible against the ever-changing regulatory and product landscape of the pharmaceutical, natural extract, food and beverage, and cosmetic and fragrance industries.

Global Allied Processing Solutions

Global Allied Processing Solutions (“G-APS”) is an international alliance of companies strategically focused on bringing leading solutions and best practices to the organic material industry. Its member companies are those on the forefront of technological advancements in processing equipment and practices that service several industries including pharmaceuticals, natural extracts, food and beverages, and cosmetics and fragrances. The goal of the alliance is to provide businesses with a singular platform comprised of multiple solutions for their processing and manufacturing infrastructure needs, with a specific focus on the extraction and purification of botanically-derived compounds and molecules. The G-APS mission is to provide operators with a vetted network of worldwide equipment suppliers that have proven results and work together seamlessly – avoiding potential overhead costs and risks when pairing machines that have not been previously tested in manufacturing settings. For more information, visit https://g-aps.com

RotaChrom Technologies

RotaChrom Technologies has developed the world’s first industrial scale Centrifugal Partition Chromatography (pCPC) technology platform with a fully automated solvent recycling system. The company’s instruments have revolutionized compound purification by providing cost-effective industrial scale chromatography solutions to customers all over the world in various industries including pharmaceutical, nutraceutical, food/beverage and botanical extracts. RotaChrom has achieved massive international success in pharmaceutical purification, and it has become an industry-leading company by setting global purification standards. RotaChrom’s CPC platforms are quintessential applications when looking for a high-purity, high-capacity, and yield-focused solution.

Heidolph Instruments

As an innovative and global corporation, we are a leader in the production of premium laboratory equipment. With our products and solutions, we support users in over 80 countries worldwide in their work. Every day, we contribute to improving the quality of life of many people. Heidolph Instruments devices and system solutions enable our customers to advance the healing and alleviation of disease. New techniques for ensuring adequate healthy foods are being developed with our products and new innovative materials can bring technological advances around the world. Other companies use our devices to manufacture, analyze; and ensure the quality of their products. Despite the wide variety of industries, all Heidolph customers have a certainty in common: they can always rely on the precision and reliability of our products. The combination of this outstanding quality with our world-leading service makes Heidolph Instruments one of the strongest partners in the laboratory equipment industry.

Media Contact:

Stephanie Plieness
CMW Media
858.264.6600
[email protected]

ATLANTA, Dec. 07, 2020 (GLOBE NEWSWIRE) — 2Checkout (now Verifone), the leading all-in-one monetization platform for global businesses, today announced that VS REVO Group – a utility software company – has considerably improved its eCommerce KPIs since switching to 2Checkout’s Avangate monetization platform.

The software company was lacking agility with its previous provider, with its eCommerce operation suffering in several areas including cart performance, technical support, and affiliate marketing. Since the switch, VS REVO Group has seen significant improvements in their digital commerce activity: a 63% improvement in cart conversion rate, and a 10% overall revenue uplift (estimated).

“Our onboarding with 2Checkout was seamless, support is very fast, and execution is impeccable. We were able to achieve in weeks and even days what in the past meant months. My team has been impressed with 2Checkout’s platform capabilities, especially the breadth and depth of subscription management and billing, which we are looking to fully leverage for our recurring business. Clearly, a beneficiary is our client base, that we can now serve in a seamless and modern way,” mentioned Tihomir Yordanov, Digital Marketing Manager at VS REVO Group.

“We are happy to have the opportunity to optimize digital commerce operations for VS REVO Group and help our client provide a better purchase experience for end-customers at a global level. At the same time, we are here to relieve clients like VS REVO Group of various privacy, sales taxation, and security regulations, enabling them to focus on interesting marketing, eCommerce, or retention campaigns. This is clearly helping them succeed and grow,” said Laurentiu Ghenciu, Global Vice President of Digital Business at Verifone.

For more information on the VS REVO Group success story, view the case study on the dedicated client page on the 2Checkout website.

About VS
REVO
Group

VS REVO Group Ltd., founded in 2007, is a software company that develops and manages various utility software products that streamline otherwise difficult processes for the average user. The group is best known for its REVO Uninstaller, a freeware-advanced uninstall utility. The VS REVO Group’s engineering team is recognized for its reliable and comprehensive new product development cycle, which includes assurance, testing, and debugging, as well as for its superior customer support.

More information on https://www.vsrevogroup.com/ and https://www.revouninstaller.com/

Ab
out 2Checkout
(now Verifone)

2Checkout (now Verifone) is the leading all-in-one monetization platform for global businesses built to help clients drive sales growth across channels and increase market share by simplifying the complexities of modern commerce. 2Checkout’s digital services, including global payments, subscription billing, merchandising, taxes, compliance and risk, help clients stay focused on innovating their products while delivering exceptional customer experiences.

In August 2020, leading global payments solution provider Verifone acquired 2Checkout, further solidifying its commitment to providing seamless and frictionless experiences to customers globally through innovative and next-generation hardware and cloud services. 2Checkout will become Verifone, and the unified company will enable omnichannel commerce wherever and whenever clients shop.

Get more information at www.2checkout.com.

Media Contact:
Delia Ene, 2Checkout
Email: [email protected] 
Tel: +31 20 890 8080 ext.: 4654

• Phase 3 trials’ topline data anticipated in the first quarter of 2021 and potential New Drug Application (NDA) submission anticipated by the end of 2021
• Roflumilast cream potential “Best in Class” topical PDE4 inhibitor
• Plaque psoriasis affects approximately 8.6 million patients in the U.S.

WESTLAKE VILLAGE, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology, today announced that the last participant has completed the 8-week treatment period in DERMIS-1 and DERMIS-2, the Company’s pivotal Phase 3 clinical trials evaluating ARQ-151 (topical roflumilast cream) as a potential topical treatment for plaque psoriasis.

“Plaque psoriasis affects approximately 8.6 million patients in the U.S., many of whom are desperate for new topical options that don’t require them to make trade-offs,” said Patrick Burnett, M.D., Ph.D., FAAD, Arcutis’ Chief Medical Officer. “We are delighted to complete DERMIS-1 and DERMIS-2, our pivotal phase 3 clinical trials evaluating roflumilast cream as a potential once daily topical treatment for plaque psoriasis. If approved, we believe roflumilast cream has the potential to eliminate the need for dermatologists and patients to compromise between efficacy and safety. We anticipate announcing topline data from these trials in the first quarter of 2021 and, if positive, anticipate submission of our NDA to the FDA by the end of 2021. We are immensely grateful to the trial participants and the clinical investigators for their time and commitment to this important research effort.”

Arcutis recently announced positive results from its Phase 2 long-term safety study in plaque psoriasis, which support chronic use of roflumilast cream. In addition, The New England Journal of Medicine published results from the double-blind, randomized Phase 2b study of roflumilast cream in plaque psoriasis.

The “Trials of PDE4 inhibition with Roflumilast for the Management of plaque PsoriasIS” One and Two (or DERMIS-1 and DERMIS-2) are identical Phase 3 randomized, parallel, double-blind, vehicle-controlled, multi-national, multi-center studies in which roflumilast 0.3% cream or vehicle cream are applied once daily for 8 weeks to subjects age 2 years and above with mild, moderate or severe chronic plaque psoriasis involving between 2% and 20% body surface area. DERMIS-1 enrolled 439 subjects, and DERMIS-2 enrolled 442 subjects. The primary endpoint of the studies is Investigator Global Assessment (IGA) Success, defined as an IGA score of clear or almost clear and at least a 2-grade improvement from baseline at week 8 on the IGA score. Multiple secondary endpoints will also be evaluated, including Intertriginous IGA (I-IGA) Success, and improvements in Psoriasis Area Severity Index (PASI), itch as measured by the Worst Itch-Numerical Rating Scale (WI-NRS) and patient perceptions of symptoms as measured by the Psoriasis Symptoms Diary (PSD). The Company anticipates topline data from the Phase 3 studies in the first quarter of 2021 and, if positive, anticipates submission of its NDA to the FDA by the end of 2021.

About
Topical Roflumilast Cream

Roflumilast Cream is a topical cream formulation of a highly potent and selective PDE4 inhibitor (roflumilast). Roflumilast has been approved by the U.S. Food and Drug Administration (FDA) for oral treatment to reduce the risk of exacerbations of chronic obstructive pulmonary disease (COPD) since 2011. Roflumilast has shown greater potency (25- to 300-fold) than the two other FDA-approved PDE4 inhibitors. PDE4 is an intracellular enzyme that increases the production of pro-inflammatory mediators and decreases production of anti-inflammatory mediators and has been implicated in a wide range of inflammatory diseases including psoriasis, eczema, and COPD. PDE4 is an established target in dermatology, and other PDE4 inhibitors have been approved by the FDA for the topical treatment of atopic dermatitis or the systemic treatment of plaque psoriasis.

About Psoriasis

Psoriasis is a common, non-contagious, immune-mediated skin disease that affects approximately 8.6 million patients in the United States. About 90% of patients develop plaque psoriasis, which is characterized by raised, red areas of skin covered with a silver or white layer of scale. Psoriatic plaques can appear on any area of the body, but most often appear on the scalp, knees, elbows, trunk, and limbs, and are often itchy and sometimes painful. Plaques in certain anatomical areas present particular treatment challenges, including the face, elbows and knees, scalp, and intertriginous regions such as the groin, axillae and inframammary areas.

About Arcutis
– Bioscience, applied to the skin.

Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT) is a late-stage biopharmaceutical company focused on developing and commercializing treatments for unmet needs in immune-mediated dermatological diseases and conditions, or immuno-dermatology. The company is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. Arcutis’ robust pipeline includes four novel drug candidates currently in development for a range of inflammatory dermatological conditions. The company’s lead product candidate, topical roflumilast, has the potential to revitalize the standard of care for plaque psoriasis, atopic dermatitis, scalp psoriasis, and seborrheic dermatitis. For more information, visit https://www.arcutis.com or follow the company on LinkedIn and Twitter.

Forward Looking Statements

This press release contains “forward-looking” statements, including, among others, statements regarding roflumilast cream’s potential as a psoriasis treatment; and expectations with regard to the timing of clinical data anticipated in the first quarter of 2021 and NDA submission by the end of 2021. These statements involve substantial known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance or achievements to be materially different from the information expressed or implied by these forward-looking statements and you should not place undue reliance on our forward-looking statements. Risks and uncertainties that may cause our actual results to differ include risks inherent in the clinical development process and regulatory approval process, the timing of regulatory filings, and our ability to defend our intellectual property. For a further description of the risks and uncertainties applicable to our business, see the “Risk Factors” section of our Form 10-Q filed with U.S. Securities and Exchange Commission (SEC) on November 5, 2020, as well as any subsequent filings with the SEC. We undertake no obligation to revise or update information herein to reflect events or circumstances in the future, even if new information becomes available.

Contact
:

Heather Rowe Armstrong
Vice President, Investor Relations & Corporate Communications
[email protected]
805-418-5006, Ext. 740